glp-1 digital health platform startups 5 Looking to Compete in the Obesity Space Novo Nordisk seeks digital health
Description
Biosci Biotechnol Biochem

Pharmacological use of GLP-1 analogs to treat obesity and diabetes The exogenous supplementation of native hormones, commonly purified from tissue homogenates, has led to numerous, seminal discoveries, most prominently the identification of insulin in 1921 [875] followed by the discovery of glucagon in 1923 [3]

Many of our patients experience not only weight loss but also enhanced energy, improved mobility, and a better quality of life

Receive an at-home impression kit to easily capture your dental impressions

LCCN 2017032267
CVS Caremark Excluded OSA Indication Too Unlike some other insurers, CVS Caremark removed Zepbound for OSA as well as weight loss in 2025
